- Home
- PHAT vs HSTM Comparison
PHAT vs HSTM Comparison
Compare PHAT & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- HSTM
- Stock Information
- Founded
- PHAT 2018
- HSTM 1990
- Country
- PHAT United States
- HSTM United States
- Employees
- PHAT N/A
- HSTM N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- HSTM Computer Software: Programming Data Processing
- Sector
- PHAT Health Care
- HSTM Technology
- Exchange
- PHAT Nasdaq
- HSTM Nasdaq
- Market Cap
- PHAT 727.5M
- HSTM 846.5M
- IPO Year
- PHAT 2019
- HSTM 2000
- Fundamental
- Price
- PHAT $9.45
- HSTM $26.86
- Analyst Decision
- PHAT Strong Buy
- HSTM Hold
- Analyst Count
- PHAT 5
- HSTM 2
- Target Price
- PHAT $16.40
- HSTM $29.00
- AVG Volume (30 Days)
- PHAT 1.7M
- HSTM 190.9K
- Earning Date
- PHAT 08-07-2025
- HSTM 07-21-2025
- Dividend Yield
- PHAT N/A
- HSTM 0.46%
- EPS Growth
- PHAT N/A
- HSTM 8.37
- EPS
- PHAT N/A
- HSTM 0.63
- Revenue
- PHAT $81,859,000.00
- HSTM $292,371,000.00
- Revenue This Year
- PHAT $195.03
- HSTM $5.00
- Revenue Next Year
- PHAT $106.77
- HSTM $5.20
- P/E Ratio
- PHAT N/A
- HSTM $42.34
- Revenue Growth
- PHAT 3055.70
- HSTM 3.36
- 52 Week Low
- PHAT $2.21
- HSTM $25.72
- 52 Week High
- PHAT $19.71
- HSTM $34.24
- Technical
- Relative Strength Index (RSI)
- PHAT 60.80
- HSTM 38.14
- Support Level
- PHAT $8.19
- HSTM $26.60
- Resistance Level
- PHAT $9.76
- HSTM $27.60
- Average True Range (ATR)
- PHAT 0.66
- HSTM 0.50
- MACD
- PHAT -0.21
- HSTM 0.03
- Stochastic Oscillator
- PHAT 54.58
- HSTM 26.25
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.